BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9519921)

  • 1. The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes.
    Stern MP
    Arch Fam Med; 1998; 7(2):155-62. PubMed ID: 9519921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic targets: what is the evidence?
    Inzucchi S; Majumdar S
    Med Clin North Am; 2015 Jan; 99(1):47-67. PubMed ID: 25456643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifactorial aspects of the treatment of the type II diabetic patient.
    Colwell JA
    Metabolism; 1997 Dec; 46(12 Suppl 1):1-4. PubMed ID: 9439550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the United Kingdom prospective diabetes study.
    Baldeweg SE; Yudkin JS
    Prim Care; 1999 Dec; 26(4):809-27. PubMed ID: 10523461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes.
    Teleb M; Popp Switzer M; Elhanafi S; Elfar A; San Juan ZT
    Curr Cardiol Rep; 2016 Mar; 18(3):29. PubMed ID: 26886228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
    Lebovitz HE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus.
    Vasudevan AR; Burns A; Fonseca VA
    Treat Endocrinol; 2006; 5(5):273-86. PubMed ID: 17002487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes.
    Boyne MS; Saudek CD
    Diabetes Care; 1999 Apr; 22 Suppl 3():C45-53. PubMed ID: 10189562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.
    Shogbon AO; Levy SB
    Am J Health Syst Pharm; 2010 May; 67(10):798-805. PubMed ID: 20479101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood glucose control and microvascular and macrovascular complications in diabetes.
    Hanssen KF
    Diabetes; 1997 Sep; 46 Suppl 2():S101-3. PubMed ID: 9285509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM
    Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinedione therapy: the benefits of aggressive and early use in type 2 diabetes.
    Reusch JE; Gadsby R
    Diabetes Technol Ther; 2003; 5(4):685-93. PubMed ID: 14511423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose control in diabetes: which target level to aim for?
    Laakso M; Cederberg H
    J Intern Med; 2012 Jul; 272(1):1-12. PubMed ID: 22321169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to ADVANCE prevention of cardiovascular complications in type 2 diabetes.
    Grobbee DE
    Metabolism; 2003 Aug; 52(8 Suppl 1):24-8. PubMed ID: 12939736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of improved glycemic control on complications in type 2 diabetes.
    Gaster B; Hirsch IB
    Arch Intern Med; 1998 Jan; 158(2):134-40. PubMed ID: 9448551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.